Thoracentesis and Paracentesis Global Market Report 2026

The thoracentesis and paracentesis market size has grown strongly in recent years. It will grow from $1.49 billion in 2025 to $1.6 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of ascites and pleural effusion, adoption of conventional thoracentesis and paracentesis procedures, increasing hospital infrastructure, awareness of minimally invasive procedures, demand for diagnostic and therapeutic procedures.

The thoracentesis and paracentesis market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growth in ultrasound-guided procedure adoption, development of advanced thoracentesis and paracentesis kits, integration with digital procedural management, expansion of ambulatory surgical centers, investment in patient safety and procedural efficiency. Major trends in the forecast period include ultrasound-guided procedure adoption, minimally invasive techniques, point-of-care fluid drainage, enhanced procedural safety measures, procedure-specific therapeutic kits.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the thoracentesis and paracentesis market in the coming years. Chronic diseases are long-term medical conditions that last for months or years, often develop gradually, and usually require continuous management rather than a complete cure. This rise in chronic disease prevalence is partly attributed to sedentary lifestyles, as prolonged inactivity and minimal physical exercise elevate the risk of conditions such as heart disease and diabetes. Thoracentesis and paracentesis aid in managing chronic diseases by offering minimally invasive procedures to remove excess fluid from the pleural or abdominal cavities, thereby alleviating symptoms and enhancing patient comfort. These procedures allow for timely monitoring and intervention in conditions such as heart failure, liver disorders, and cancers, reducing complications and improving overall disease management and quality of life. For example, in April 2025, data from the Centers for Disease Control and Prevention, a U.S.-based government agency, reported that in 2023, roughly 76.4% of U.S. adults (194 million) had at least one chronic condition, with 51.4% (131 million) affected by multiple chronic conditions. Consequently, the rising prevalence of chronic diseases is fueling the growth of the thoracentesis and paracentesis market.

Key companies operating in the thoracentesis and paracentesis market are focusing on developing technologically advanced solutions, such as fluid drainage automation, to enhance procedural safety, reduce patient discomfort, improve clinical efficiency, and enable real-time monitoring for better treatment outcomes. Fluid drainage automation is the use of devices or systems to automatically control the removal of bodily fluids from cavities, regulating flow, pressure, and safety to improve efficiency and patient comfort. For example, in January 2024, Laborie Medical Technologies Inc., a US-based medical technology company, introduced the RenovarP Centesis System. It is a fluid drainage device that builds upon an existing paracentesis pump by adding an expanded indication for thoracentesis. It includes design enhancements to the handle and nest, improving the overall user experience for healthcare professionals. It offers a safe, efficient, and minimally invasive solution for draining fluid from the abdomen (paracentesis) and chest (thoracentesis), aiming to improve patient comfort and reduce recovery times.

The growing healthcare expenditure is expected to further support the expansion of the thoracentesis and paracentesis market in the coming years. Healthcare spending encompasses the total funds allocated to medical services, products, and public health initiatives aimed at preventing, diagnosing, treating, and managing illnesses, as well as maintaining overall health. The rising need for healthcare investment is driven by the increasing prevalence of chronic diseases, which require prolonged and often expensive treatments. Thoracentesis and paracentesis contribute to cost reduction in healthcare by providing minimally invasive fluid removal, which shortens hospital stays, lowers complication rates, and decreases the necessity for costly interventions. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure in 2023 rose by 5.6% in nominal terms, marking a 0.9% increase compared to 2022. Thus, escalating healthcare spending is propelling the growth of the thoracentesis and paracentesis market.

Major companies operating in the thoracentesis paracentesis market are Cardinal Health Inc., Medtronic plc, Becton Dickinson Company, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Redax S.p.A., Avanos Medical Inc., Poly Medicure Ltd., Axiom Medical Inc., Angiplast Private Limited, Utah Medical Products Inc., Mermaid Medical A/S, PFM Medical AG, ITL Australia Pty Ltd, ATMOS MedizinTechnik GmbH & Co. KG, Vygon SA, PolyMed Medical Devices Pvt. Ltd., Sterimed Medical Devices Pvt. Ltd., Blue Neem Medical Devices Pvt. Ltd.

North America was the largest region in the thoracentesis and paracentesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thoracentesis and paracentesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thoracentesis and paracentesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thoracentesis and paracentesis market includes revenues earned by entities through procedure assistance, device maintenance, clinical training, hospital implementation, technical support, patient monitoring, post procedure care, and healthcare consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thoracentesis and paracentesis are clinical procedures designed to remove excess fluid from the pleural and peritoneal cavities, respectively. These interventions relieve symptoms such as breathing difficulty and abdominal discomfort caused by fluid buildup and are carried out using specialized needles and catheter systems to ensure safe and effective drainage.

The key procedure types of thoracentesis and paracentesis include ultrasound-guided and blind or conventional procedures. Ultrasound-guided procedures use imaging to safely remove fluid from the pleural or abdominal cavity for diagnostic or therapeutic purposes. Product types include thoracentesis kits, paracentesis kits, and others, indicated for conditions such as ascites, pleural effusion, empyema, and hemothorax. Applications include diagnostic and therapeutic procedures, serving hospitals, clinics, ambulatory surgical centers, and other end users.

Tariffs have affected the thoracentesis and paracentesis market by increasing the cost of importing specialized procedure kits, ultrasound devices, and consumables. This has impacted segments such as thoracentesis kits, paracentesis kits, and ultrasound-guided procedures, particularly in regions like North America and Europe that rely on imports for high-precision medical equipment. While tariffs pose challenges, they are driving local manufacturing initiatives and innovation in cost-effective, domestically produced kits, enhancing procedural accessibility and supporting market growth.

The thoracentesis and paracentesis market research report is one of a series of new reports that provides thoracentesis and paracentesis market statistics, including thoracentesis and paracentesis industry global market size, regional shares, competitors with a thoracentesis and paracentesis market share, detailed thoracentesis and paracentesis market segments, market trends and opportunities, and any further data you may need to thrive in the thoracentesis and paracentesis industry. This thoracentesis and paracentesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.